Introduction {#s1}
============

Colorectal cancer (CRC) is the third most common cancer diagnosed in men and women and is the third leading cause of cancer death in the United States [@pone.0071211-ACS1]. In 2011, there were approximately 141,210 individuals diagnosed with CRC and 49,380 deaths from this disease in the United States [@pone.0071211-ACS1]. More than 80% of CRC evolve from neoplastic adenomatous polyps or adenomas [@pone.0071211-Stewart1]. Prevalence of adenomas is estimated at 30% at age 50 and 40% by age 60 [@pone.0071211-Goroll1]. Compared to small (\<1 cm) adenomas, larger ones (≥ 1 cm) have a greater potential to grow and progress into CRC [@pone.0071211-Atkin1]. Use of endoscopy screening with polyp removal has significantly reduced CRC incidence and mortality [@pone.0071211-Winawer1], [@pone.0071211-Winawer2], reinforcing the pathogenetic relationship between adenomas and CRC. Therefore, the identification of risk factors for adenoma development has significant public health implications.

Cigarette smoking [@pone.0071211-Terry1], [@pone.0071211-Botteri1] and folate deficiency [@pone.0071211-Duthie1] are established adenoma risk factors, whereas folate supplementation may promote progression of established adenomas [@pone.0071211-Mason1]. Cigarette smoke contains reactive oxygen species (ROS) and chemical carcinogens [@pone.0071211-Pryor1] which can damage DNA [@pone.0071211-Pryor1], [@pone.0071211-Friedberg1]. Additionally, smoking has been associated with decreased folate levels [@pone.0071211-Mannino1], which may contribute to folate deficiency, which is associated with double strand breaks and abasic sites [@pone.0071211-Blount1].

Alcohol consumption is currently considered a convincing CRC risk factor [@pone.0071211-Secretan1], [@pone.0071211-American1]. Increasing alcohol intake has previously been shown to reduce folate levels [@pone.0071211-Baron1], [@pone.0071211-Seitz1]. Alcohol metabolism generates acetaldehyde, a known mutagen which generate ROS in the colon lumen [@pone.0071211-Poschl1], [@pone.0071211-Kune1], directly inhibits O^6^ methylguanine-methyl-transferase, an enzyme involved in removal of alkylation-induced DNA damage, and leads to hyper regeneration of crypt cells which induces multiple forms of DNA damage [@pone.0071211-Poschl1], [@pone.0071211-Brooks1]. In addition, alcohol metabolism can induce cytochrome P450 enzymes, which can increase activation of chemical pro-carcinogens [@pone.0071211-Poschl1], [@pone.0071211-Seitz2], [@pone.0071211-Das1].

Overall, smoking, alcohol consumption and decreased folate availability can lead to oxidative DNA damage and excess uracil misincorporation, which may all contribute to adenoma development. The base excision repair (BER) pathway, is the predominant mechanism for repair of oxidative DNA damage [@pone.0071211-Robertson1]. We hypothesized that genetic variation in BER genes may modify the risk of colorectal adenomas, in particular, in combination with smoking, alcohol, and low dietary folate. We examined potential associations between single nucleotide polymorphisms (SNPs) in genes involved in BER and distal adenoma risk, and considered their role as potential modifiers of the effect of cigarette smoking, alcohol consumption, and dietary folate intake. Using data and samples from a sigmoidoscopy-based study conducted in Los Angeles County we comprehensively investigated associations between genetic variation in 14 BER genes and colorectal adenoma risk.

Methods {#s2}
=======

Ethics Statement {#s2a}
----------------

The research protocol was approved by the institutional review boards at both USC and Kaiser Permanente, and all subjects signed a written informed consent approved by both institutions.

Study Subjects {#s2b}
--------------

Study participants were enrolled in a University of Southern California/Kaiser Permanente study of risk factors for colorectal adenomas. All individuals were examined by flexible sigmoidoscopy from 1991 to 1993 (phase I) and from 1993 to 1995 (phase II) at one of two southern California Kaiser Permanente clinics (Bellflower or Sunset), and were recruited using identical criteria, as we have previously described [@pone.0071211-Stern1], [@pone.0071211-Stern2]. Briefly, cases were individuals with a first-time diagnosis of a histologically confirmed adenoma. Controls were selected from the remaining eligible individuals who did not present with polyps at sigmoidoscopy examination and had no past history of histologically confirmed adenomas. Controls were individually matched to cases by gender, age (within 5 years), sigmoidoscopy date (within 3 months), and Kaiser Permanente clinic. All subjects signed a written informed consent approved by the Institutional Review Board, donated a blood sample, and completed two questionnaires. A risk factor questionnaire was administered during an in-person interview, and collected data on demographics, smoking history, family history of cancer, physical activity and other factors described previously [@pone.0071211-Lin1], [@pone.0071211-Longnecker1]. A semi-quantitative food frequency questionnaire was administered in reference to diet during the year before sigmoidoscopy examination, as previously described [@pone.0071211-Haile1].

SNP Selection and Genotyping {#s2c}
----------------------------

TagSNPs for each BER gene were selected using Haploview Tagger [@pone.0071211-Barrett1] based on the HapMap CEPH (CEU) population using the following criteria: minor allele frequency (MAF) ≥5%, pairwise r^2^≥0.95, and a distance from the closest SNP greater than 60 base pairs on the Illumina platform. Linkage disequilibrium (LD) blocks were defined using data from HapMap data release \#16c.1, June 2005, on NCBI B34 assembly, dbSNP b124. For each gene, we included the 5′- and 3′-most SNP within the LD block within ∼10 kb upstream and ∼5 kb downstream. In regions of no or low LD, tagSNPs with a MAF ≥5% at a density of ∼ 1 per kb were selected from either HapMap or dbSNP. In this analysis, we report our results for 182 tagSNPs across 14 genes that participate in the BER pathway ([Table 1](#pone-0071211-t001){ref-type="table"} and [Table S1](#pone.0071211.s001){ref-type="supplementary-material"}). TagSNPs were genotyped on the Illumina GoldenGate platform, as we previously described [@pone.0071211-Levine1]. Among the BER genes in our study, we required that all 182 tagSNPs have call rates ≥0.90 and that we not observe evidence of statistically significant deviations of observed from expected values, when assuming Hardy-Weinberg equilibrium ≥0.00027 using exact tests (Bonferroni-corrected p value; α = 0.05/182). All tagSNPs met these two requirements. Additionally, we required all individuals had overall call rates ≥90%, which led to exclusion from analyses of 89 individuals. We included in final analyses genotype data from 1,368 (94%; 677 cases and 691 controls) of 1,457 total subjects in this study. Demographic and matching characteristics for individuals with and without genotype data were not statistically significantly different.

10.1371/journal.pone.0071211.t001

###### Base excision repair pathway genes investigated.

![](pone.0071211.t001){#pone-0071211-t001-1}

  Gene Symbol    \# tagSNPs   Chromosomal location         Protein Function
  ------------- ------------ ---------------------- ------------------------------
  *APEX1*            13             14q11.2                  Endonuclease
  *FEN1*             7               11q12                   Endonuclease
  *LIG1*             23          19q13.2-q13.3                  Ligase
  *LIG3*             7            17q11.2-q12                   Ligase
  *MUTYH*            7               1p34.1                  Glycosylase
  *NEIL1*            4              15q33.33                 Glycosylase
  *NEIL2*            43              8p23.1                  Glycosylase
  *NTHL1*            9              16p13.3          Endonuclease and Glycosylase
  *OGG1*             7                3p26                   Glycosylase
  *PARP1*            18             1q41-q42            poly(ADP-ribosyl)ation
  *POLβ*             6              8p12-p11                  Polymerase
  *POLD1*            7              19q13.3                   Polymerase
  *SMUG1*            10          12q13.11--13.3              Glycosylase
  *XRCC1*            21             19q13.2              Scaffolding protein

Genes are listed according to HUGO gene nomenclature format (<http://www.genenames.org>), Abbreviations: APEX1, APEX nuclease 1; FEN1, flap structure-specific endonuclease 1; LIG1, ligase I, DNA, ATP-dependent; LIG3, ligase III, DNA, ATP-dependent; MUTYH, mutY homolog (E. coli); NEIL1, nei endonuclease VIII-like 1 (E. coli); NEIL2, nei endonuclease VIII-like 2 (E. coli); NTHL1, nth endonuclease III-like 1 (E. coli); OGG1, 8-oxoguanine DNA glycosylase; PARP, poly (ADP-ribose) polymerase 1; POLβ, polymerase (DNA directed),beta; POLD1, polymerase (DNA directed), delta 1, catalytic subunit 125 kDa; SMUG1, single-strand-selective monofunctional uracil-DNA glycosylase 1; XRCC1, X-ray repair complementing defective repair in Chinese hamster cells 1.

Statistical Analysis {#s2d}
--------------------

### SNP main effect analyses {#s2d1}

Deviations of observed genotype frequencies from those expected when assuming HWE were examined among controls by race/ethnicity using exact tests. We used unconditional logistic regression, assuming a log-additive model, to estimate per-allele odds ratios (ORs) and corresponding 95% confidence intervals (95% CIs) for the association between genotype and adenoma risk, adjusting for race (Non-Hispanic Whites, Latinos, African-American, Asian/Pacific Islander), study phase (phase I/phase II), age at sigmoidoscopy (continuous), gender, exam date, and clinic (Bellflower or Sunset). In this study, similar results are obtained when using unconditional logistic regression adjusting for the matching factors as using conditional logistic regression, with the benefit of using all genotype information in the study population [@pone.0071211-Stern2]. Additional control for the following adenoma risk factors did not change ORs by more than 10%; therefore, they were not included in final analyses: alcohol intake (g/day), smoking status, dietary folate intake (mcg/day), body mass index, multivitamin use (yes/no), total caloric intake, total dietary fiber (g/day).

When testing SNP main effects we corrected for multiple testing within each gene region as well as across all BER gene regions investigated. Specifically, for each tagSNP obtained under a log-additive model, p-values were corrected for multiple testing, taking into account multiple correlated tests due to LD between SNPs within each gene region, using the P~ACT~ (p-value adjusted for correlated tests) method implemented in the P~ACT~ R package [@pone.0071211-Conneely1]. Additionally, we corrected for multiple testing between gene regions by applying a Bonferroni correction multiplying each P~ACT~ p-value by the 14 investigated BER gene regions to determine overall pathway significance (p~pathway~) [@pone.0071211-Storey1]. We assessed potential heterogeneity of SNP main effects by race/ethnicity (among tagSNPs with MAF \>5% in controls for each race/ethnicity), by performing 3df likelihood-ratio tests of interaction between genotypes and race/ethnicity. We used multinomial logistic regression to examine differences in SNP main effects by adenoma location (rectal versus left colon) and adenoma size (\<1 cm) versus ≥1 cm) with respect to the control group. SNP main effect p-values for stratified analyses were corrected using P~ACT~ as described above. When considering linkage between different SNPs we used the square of the correlation coefficient (R^2^) to estimate pairwise LD using Haploview [@pone.0071211-Barrett1].

### TagSNP × environmental risk factor interactions {#s2d2}

We investigated whether BER genes tagSNPs modify the effect of alcohol use, dietary folate intake, or smoking in all individuals and in non-Hispanic Whites (NHW) only. We categorized smoking variables using median values among smoking controls to create the following variables: smoking status (never, quit, current), years of smoking (0, ≤26 years, \>26 years), pack-years smoked (0, ≤21 pack years, \>21 pack years). We also considered the following alcohol intake variables: number of drinks per day (never, ≤1 drink/day, \>1 drink/day) and median daily alcohol intake (using median intake among drinking controls as a cut point: 0, ≤6 g/d, \>6 g/d), with one alcoholic drink per day defined as approximately 15 grams of ethanol. We considered a dietary folate intake variable (low/medium/high) defined using tertiles of dietary folate intake among controls as cut points: ≤267 mcg/day, \>267--387 mcg/day, ≥388 mcg/day).

Analyses of gene-environment interactions (GxE) were conducted by testing interaction terms between tagSNPs (assuming a log-additive model) and each environmental exposure using likelihood ratio tests based on unconditional logistic regression. To reduce the multiple testing burden and avoid possible failure of asymptotic tests, any tagSNPs for which a genotypic category count was less than 10 for any of the environmental factor strata considered was not included in analyses. Gene-exposure interactions were mutually adjusted for all three exposures considered. Further adjustment for body mass index, multivitamin use (yes/no), total caloric intake, or total dietary fiber (g/day) produced almost identical estimates; therefore we did not keep these variables in the models.

We corrected for multiple testing by applying two Bonferroni corrections to the crude interaction p-values which we report separately: first, we applied a within gene region Bonferroni correction (interaction p~gene~), by considering the number of tagSNPs in its respective gene region; second, we applied an overall pathway Bonferroni correction (interaction p~pathway~), by considering the 14 investigated BER gene regions. Statistical significance was declared if either corrected p-values were \<0.05. All tests conducted were two sided and all statistical analysis were conducted using Stata 11 SE (Stata Corporation, College Station, TX) and the R programming language (The R Project for Statistical Computing, <http://www.r-project.org>).

Results {#s3}
=======

Demographic characteristics of all cases (N = 721) and controls (N = 736) in our study are summarized in [Table 2](#pone-0071211-t002){ref-type="table"}. As we previously described [@pone.0071211-Stern1], there were no differences in age, gender, ethnicity, alcohol intake and smoking patterns between Phase I and Phase II participants. However, Phase II participants had higher dietary folate intake than those who participated in phase I (p = \<0.001). Fifty-two percent of enrolled subjects were NHW. The mean age of cases was 61.46 years (±6.75) and the mean age of controls was 61.67 years (±6.88). Cases smoked longer and more intensely than controls and were more likely to be current smokers (p\<0.001). Cases were also found to have a lower mean dietary folate intake (mcg/d) and a lower mean dietary fiber intake (g/d) than controls (p = 0.013; p = 0.036). Approximately 81% of adenomas were colon adenomas and approximately 67% were small adenomas (\<1 cm).

10.1371/journal.pone.0071211.t002

###### Demographics and descriptive characteristics of cases and controls.
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                                        Controls   Cases                     
  ------------------------------------ ---------- -------- -------- -------- ---------
  Mean age at interview,y (±SD)          61.46      6.75    61.67     6.88     0.550
  Mean Smoking years,y (±SD)              14.6     16.77    18.52    17.86    \<0.001
  Mean smoking packyears, (±SD)          16.61     31.51    21.04    31.51     0.008
  Mean alcohol intake, y (±SD)            8.03     14.76     9.44    18.54     0.108
  Mean dietary folate, mcg/day (±SD)     366.63    210.28   340.08   194.28    0.013
  Mean Calories (±SD)                   2046.25    951.76    2081    924.43    0.473
  Mean dietary fiber, g/day (±SD)        22.84     13.18    21.43    12.67     0.036
  Mean saturated fat, g/day (±SD)        23.37     13.38     24.4    13.42     0.147
  Mean BMI (±SD)                         27.08      4.79    27.57     4.61     0.051
  Median Age at interview,y                                                  
  ≤60 yrs                                 331      44.97     313     43.41     0.549
  \>60 yrs                                405      55.03     408     56.59   
  Race/ethnicity                                                             
  non-Hispanic White                      386      52.59     372     52.10     0.344
  African-American                        112      15.26     126     17.65   
  Hispanic                                149      20.30     123     17.23   
  Asian-Pacific Islander                   79      10.76      80     11.20   
  Other                                    8        1.09      13      1.82   
  Sex                                                                        
  Male                                    479      65.17     465     64.49     0.787
  Female                                  256      34.83     256     35.51   
  Clinic of diagnosis                                                        
  Bellflower                              472      64.13     464     64.36     0.929
  Sunset                                  264      35.87     257     35.64   
  Study Phase                                                                
  Phase I                                 460      62.50     438     60.75     0.492
  Phase II                                276      37.50     283     39.25   
  Number of Adenomas                                                         
  1                                                          638     88.73   
  ≥2                                                          81     11.27   
  Missing                                                     2              
  Adenoma site                                                               
  Rectum (\<15 cm)                                           137     19.13   
  Colon (≥15 cm)                                             579     80.87   
  Missing                                                     5              
  Adenoma size                                                               
  Small (\<1 cm)                                             476     66.85   
  Large (≥1 cm)                                              236     33.15   
  Missing                                                     9              
  Smoking                                                                    
  Never                                   301      42.94     253     36.77    \<0.001
  Former                                  326      46.50     312     45.35   
  Current                                  74      10.56     123     17.88   
  Missing                                  35                 33             
  Smoking years                                                              
  Never                                   301      43.43     253     37.21    \<0.001
  \>0--26 yrs                             198      28.57     168     24.71   
  \>26 yrs                                194      27.99     259     38.09   
  Missing                                  43                 41             
  Smoking Pack-years                                                         
  Never                                   301      43.56     253     37.26     0.001
  \>0--21                                 196      28.36     171     25.18   
  \>21                                    194      28.08     255     37.56   
  Alcohol intake                                                             
  Never                                   283      38.45     268     37.33     0.323
  ≤6 g/day                                227      30.84     204     27.41   
  \>6 g/day                               226      30.71     246     34.26   
  Missing                                  0                  3              
  Alcohol intake                                                             
  Never                                   283      38.45     268     37.33     0.864
  ≤15 g/day                               333      45.24     327     45.54   
  \>15 g/day−30 g/day                      50       6.79      46      6.41   
  \>30 g/day                               70       9.51      77     10.72   
  Missing                                  0                  3              
  Alcohol intake                                                             
  Never                                   283      38.45     268     37.33     0.871
  ≤15 g/day                               333      45.24     327     45.54   
  \>15 g/day                              120      16.30     123     17.13   
  Missing                                  0                  3              
  Dietary folate                                                             
  Low (≤267 mcg/day)                      248      33.70     283     40.60     0.024
  Medium (\>267--387 mcg/day)             241      32.74     210     30.13   
  High (≥388 mcg/day)                     247      33.56     204     29.27   
  Missing                                                                    
  Multivitamin use                                                           
  No                                      303      41.28     293     42.40     0.668
  Yes                                     431      58.72     398     57.60   
  Missing                                  2                  30             

BER Genes and Colorectal Adenoma Risk {#s3a}
-------------------------------------

Among all individuals combined, out of the 182 tagSNPs only *NEIL2* rs11785481 showed a statistically significant association with adenoma risk; however, it was not statistically significant after multiple comparisons adjustment within gene region (P~ACT~) (OR = 0.70; 95%CI = 0.55--0.90; p = 0.006; P~ACT~ = 0.140) ([Table 3](#pone-0071211-t003){ref-type="table"}).

10.1371/journal.pone.0071211.t003

###### Colorectal adenoma SNP associations among the entire population and stratified by race/ethnicity.
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  Gene                         SNP                     All combined   Non-Hispanic White   African-American    Hispanic    Asian-Pacific Islander   P~het~ [e](#nt106){ref-type="table-fn"}
  --------- ----------------------------------------- -------------- -------------------- ------------------ ------------ ------------------------ -----------------------------------------
  *NEIL2*                  rs11785481                                                                                                                                0.131
              Ca/Co[a](#nt102){ref-type="table-fn"}      666/692           354/364             121/109         116/140             75/79           
               OR [b](#nt103){ref-type="table-fn"}         0.70              0.64                0.60            1.29               0.25           
                              95%CI                     0.55--0.90        0.48--0.87          0.24--1.53      0.72--2.31         0.05--1.37        
                p[c](#nt104){ref-type="table-fn"}         0.006             0.004               0.286           0.387              0.111           
             p~ACT~ [d](#nt105){ref-type="table-fn"}      0.139             0.089               1.000           1.000              0.806           
  *FEN1*                    rs108499                                                                                                                                 0.024
              Ca/Co[a](#nt102){ref-type="table-fn"}      691/663           353/365             122/109         113/140             75/77           
               OR [b](#nt103){ref-type="table-fn"}         1.06              0.95                0.67            1.09               2.12           
                              95%CI                     0.90--1.25        0.76--1.18          0.37--1.21      0.76--1.57         1.30--3.45        
                p[c](#nt104){ref-type="table-fn"}         0.516             0.635               0.185           0.641              0.002           
             p~ACT~ [d](#nt105){ref-type="table-fn"}      1.000             1.000               0.645           1.000              0.009           
  *APEX1*                  rs17111750                                                                                                                                0.004
              Ca/Co[a](#nt102){ref-type="table-fn"}      695/664           354/367             121/110         114/140             75/78           
               OR [b](#nt103){ref-type="table-fn"}         1.00              0.88                2.19            0.78               1.04           
                              95%CI                     0.85--1.18        0.71--1.10          1.36--3.55      0.52--1.15         0.58--1.86        
                p[c](#nt104){ref-type="table-fn"}         0.981             0.271               0.001           0.208              0.897           
             p~ACT~ [d](#nt105){ref-type="table-fn"}      1.000             0.781               0.013           0.573              1.000           
  *FEN1*                    rs509360                     697/665                                                                                                     0.052
              Ca/Co[a](#nt102){ref-type="table-fn"}      697/665           353/367             122/111         116/140             74/79           
               OR [b](#nt103){ref-type="table-fn"}         0.93              0.95                1.27            1.09               0.49           
                              95%CI                     0.78--1.09        0.76--1.19          0.81--2.01      0.71--1.68         0.30--0.79        
                p[c](#nt104){ref-type="table-fn"}         0.358             0.662               0.302           0.694              0.003           
             p~ACT~ [d](#nt105){ref-type="table-fn"}      0.888             1.000               0.746           1.000              0.011           
  *NTHL1*                   rs2516781                                                                                                                                0.062
              Ca/Co[a](#nt102){ref-type="table-fn"}      688/664           353/363             122/108         115/140             74/77           
               OR [b](#nt103){ref-type="table-fn"}         0.91              1.01                0.83            1.06               0.45           
                              95%CI                     0.77--1.08        0.80--1.27          0.51--1.34      0.74--1.52         0.25--0.80        
                p[c](#nt104){ref-type="table-fn"}         0.271             0.960               0.445           0.747              0.006           
             p~ACT~ [d](#nt105){ref-type="table-fn"}      0.840             1.000               0.960           1.000              0.033           

Excludes 21 individuals who characterized their race/ethnic group as \"other\";

Per-allele ORs and 95%confidence intervals computed using logistic regression assuming a log-additive model and adjusting for age, exam date, sex, clinic, study phase and race among all study participants;

Crude p-value;

Crude p-value corrected for multiple comparisons using P~ACT~;

Race/ethnicity specific per-allele ORs and 95% confidence intervals computed using logistic regression assuming a log-additive model and adjusting for the matching factors age, exam date, sex, clinic, study phase; ^e^ p-value for heterogeneity by race.

When considering stratified analyses by racial/ethnic group, among African-Americans we observed an association with *APEX1* rs17111750 (OR = 2.19; 95%CI = 1.36--3.55; P~ACT~ = 0.013; p~pathway~ = 0.180; p~heterogeneity~ = 0.004)([Table 3](#pone-0071211-t003){ref-type="table"}). Among Asian-Pacific Islanders we observed an association with two tagSNPs in the *FEN1* gene, rs108499 (OR = 2.12; 95%CI = 1.30--3.45; P~ACT~ = 0.009; p~pathway~ = 0.129; p~heterogeneity~ = 0.024) and rs509360 (OR = 0.40; 95%CI = 0.30--0.79; P~ACT~ = 0.011; p~pathway~ = 0.159; p~heterogeneity~ = 0.052), and one tagSNP in *NTHL1,* rs2516781 (OR = 0.45; 95%CI = 0.25--0.80; P~ACT~ = 0.032; p~pathway~ = 0.461; p~heterogeneity~ = 0.062)([Table 3](#pone-0071211-t003){ref-type="table"}). All estimates of per-allele associations for adenoma risk among all individuals combined and by race/ethnicity are shown in [Table S2](#pone.0071211.s002){ref-type="supplementary-material"}.

BER Genes and Adenoma Risk Taking into Account Adenoma Size and Location {#s3b}
------------------------------------------------------------------------

We did not find evidence of any statistically significant per-allele associations within either the small polyp (\<1 cm) or large polyp (≥1 cm) group after multiple comparisons adjustment within gene region (P~ACT~). When adenomas location (colon versus rectum), we observed two *NEIL2* tagSNPs were associated with increased risk for rectal adenomas: *NEIL2* rs7015453 (OR = 1.72; 95%CI = 1.24--2.39; P~ACT~ = 0.025; p~heterogeneity~ = 0.003) and rs3757949 (OR = 1.58; 95%CI = 1.18--2.13; P~ACT~ = 0.044; p~heterogeneity~ = 0.004) ([Table 4](#pone-0071211-t004){ref-type="table"} *).* These two tagSNPs were not found to be in LD among NHW (r^2^ = 0.11), among whom we observed similar findings (data not shown). Complete data for analysis by adenoma location can be found in [Table S3](#pone.0071211.s003){ref-type="supplementary-material"}.

10.1371/journal.pone.0071211.t004

###### Significant BER per-allele associations by polyp sub-site.
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                         Rectal Polyp   Colon Polyp   Rectal/Colon                                                                                
  --------- ----------- -------------- ------------- -------------- ------- ------- ------- --------- ------ ------------ ------- ------- ------- -------
  *NEIL2*    rs3757949     123/669         1.58        1.18--2.13    0.002   0.044   0.610   528/669   1.02   0.85--1.23   0.795   1.000   1.000   0.004
  *NEIL2*    rs7015453     123/670         1.72        1.24--2.39    0.001   0.025   0.346   525/670   1.03   0.84--1.27   0.738   1.000   1.000   0.003

Excludes 21 individuals who characterized their race/ethnic group as \"other.\";

Per-allele ORs and 95%confidence intervals computed using multinomial logistic regression assuming a log-additive model and adjusting for age, exam date, sex, clinic, study phase, and race among all study participants;

Crude p-value;

Crude p-value corrected for multiple comparisons using P~ACT~;

Pathway wide (p~pathway~) p-value based on Bonferroni correction of P~ACT~ for the number of BER gene regions investigated (N = 14);

p-value for heterogeneity by polyp subsite.

Genetic Variation in BER Genes, Adenoma Risk and Alcohol {#s3c}
--------------------------------------------------------

Statistically significant interactions were observed for *LIG3* rs1052536 and amount (0 g/day, ≤6 g/day, \>6 g/day; interaction p~gene~ = 0.019, interaction p~pathway = ~0.241) and frequency of alcohol intake (never, 1 drink/day, \>1 drink/day; interaction p~gene~ = 0.029, interaction p~pathway = ~0.345) ([Table 5](#pone-0071211-t005){ref-type="table"}). Specifically, among carriers of two major (C) alleles, those who drank more than one drink per day had an 84% increased risk of adenoma compared with non-drinkers (OR = 1.84; 95%CI = 1.09--3.11; p = 0.022; p ~for\ trend~ = 0.024), and those who drank more than 6 grams per day had a 77% increased risk of adenoma compared with non-drinkers (OR = 1.77; 95%CI = 1.17--2.68; p = 0.006; p ~for\ trend~ = 0.003). There was no association between alcohol and adenoma risk for subjects with 1 minor (T) allele ([Table 5](#pone-0071211-t005){ref-type="table"}). When restricting analyses to NHW we observed interactions for *LIG3* rs1052536 that were of similar magnitude although not statistically significant (data not shown).

10.1371/journal.pone.0071211.t005

###### Smoking, alcohol, dietary folate and adenoma risk by genotype among all subjects.

![](pone.0071211.t005){#pone-0071211-t005-5}

  Exposure variable              CA/CO     CA/CO    CA/CO                                                            OR [a,b,c](#nt113){ref-type="table-fn"}                                                             95%CI         P      OR [a,b,c](#nt113){ref-type="table-fn"}     95%CI         P      OR [a,b,c](#nt113){ref-type="table-fn"}     95%CI         P
  ---------------------------- --------- --------- -------- --------------------------------------------------------------------------------------------------------------------------------------------------------- ------------ --------- ----------------------------------------- ------------ --------- ----------------------------------------- ------------ ---------
  *LIG3* rs105236                                                                                                                                                                                                                                                                                                                                                    
  Alcohol Intake                  CC        CT        TT                                                                               C/C                                                                                C/T         T/T                                                                                                                            
  Never                         97/108    99/106    34/30                                                                            1^ref^                                                                                                                   1^ref^                                                           1^ref^                                
  ≤6 g/day                       67/81     73/76    31/38                                                                             1.05                                                                             0.70--1.58    0.818                     0.90                     0.67--1.22    0.499                     0.77                     0.44--1.35    0.369
  \>6 g/day                      89/61     99/99    23/38                                                                             1.77                                                                             1.17--2.68    0.006                     1.01                     0.75--1.36    0.962                     0.57                     0.32--1.01    0.053
  p ~trend~                                                                                                                                                                                                                          0.003                                                            0.719                                                            0.071
                                                             interaction p^d = ^0.005; interaction p~gene~ [e](#nt117){ref-type="table-fn"} = 0.019; interaction p~pathway~ [f](#nt118){ref-type="table-fn"} = 0.241                                                                                                                                                 
  **Alcoholic Drinks**          **CC**    **CT**    **TT**                                                                           **C/C**                                                                            **C/T**     **T/T**                                                                                                                          
  Never                         97/108    99/106    34/30                                                                            1^ref^                                                                                                                   1^ref^                                                           1^ref^                                
  ≤1 drink/day                  112/116   121/117   41/56                                                                             1.24                                                                             0.86--1.80    0.247                     0.96                     0.73--1.26    0.752                     0.74                     0.44--1.23    0.243
  \>1 drink/day                  44/26     51/58    13/20                                                                             1.84                                                                             1.09--3.11    0.022                     0.97                     0.67--1.38    0.848                     0.51                     0.25--1.01    0.052
  p ~trend~                                                                                                                                                                                                                          0.024                                                            0.807                                                            0.048
                                                             interaction p^d = ^0.010; interaction p~gene~ [e](#nt117){ref-type="table-fn"} = 0.029; interaction p~pathway~ [f](#nt118){ref-type="table-fn"} = 0.345                                                                                                                                                 
  **Folate mcg/day**            **CC**    **CT**    **TT**                                                                           **C/C**                                                                            **C/T**     **T/T**                                                                                                                          
  ≤267                          106/101   110/92    36/26                                                                            1^ref^                                                                                                                   1^ref^                                                           1^ref^                                
  \>267--387                     65/85     84/89    31/38                                                                             0.77                                                                             0.52--1.15    0.205                     0.74                     0.55--0.99    0.040                     0.70                     0.40--1.23    0.215
  ≥388                           82/64    77/100    21/42                                                                             1.29                                                                             0.86--1.93    0.212                     0.69                     0.51--0.93    0.015                     0.37                     0.20--0.65    0.001
  p ~trend~                                                                                                                                                                                                                          0.175                                                            0.021                                                           \<0.001
                                                             interaction p^d = ^0.001; interaction p~gene~ [e](#nt117){ref-type="table-fn"} = 0.006; interaction p~pathway~ [f](#nt118){ref-type="table-fn"} = 0.081                                                                                                                                                 
  ***LIG3*** **rs3744358**                                                                                                                                                                                                                                                                                                                                           
  **Folate mcg/day**            **TT**    **TG**    **GG**                                                                           **T/T**                                                                            **T/G**     **G/G**                                                                                                                          
  ≤267                          139/128    91/79    22/12                                                                            1^ref^                                                                                                                   1^ref^                                                           1^ref^                                
  \>267--387                    81/117     74/74    26/19                                                                             0.66                                                                             0.46--0.94    0.022                     0.83                     0.59--1.16    0.269                     1.05                     0.54--2.04    0.890
  ≥388                          103/100    65/80    11/26                                                                             1.07                                                                             0.75--1.53    0.719                     0.63                     0.45--0.90    0.010                     0.38                     0.19--0.75    0.006
  p ~trend~                                                                                                                                                                                                                          0.577                                                            0.010                                                            0.003
                                                             interaction p^d = ^0.008; interaction p~gene~ [e](#nt117){ref-type="table-fn"} = 0.032; interaction p~pathway~ [f](#nt118){ref-type="table-fn"} = 0.451                                                                                                                                                 
  ***MUTYH*** **rs10890324**                                                                                                                                                                                                                                                                                                                                         
  **Smoking Pack-yrs**          **AA**    **AG**    **GG**                                                                           **A/A**                                                                            **A/G**     **G/G**                                                                                                                          
  Never                         116/132   89/108    25/32                                                                            1^ref^                                                                                                                   1^ref^                                                           1^ref^                                
  \>0--21                        75/86     59/74    20/24                                                                             0.98                                                                             0.67--1.45    0.928                     0.99                     0.72--1.36    0.950                     1.00                     0.54--1.86    0.993
  \>21                           95/99     89/64    44/18                                                                             1.02                                                                             0.70--1.49    0.903                     1.76                     1.29--2.42   \<0.001                    3.03                     1.67--5.51   \<0.001
  p ~trend~                                                                                                                                                                                                                          0.871                                                           \<0.001                                                          \<0.001
                                                             interaction p^d = ^0.002; interaction p~gene~ [e](#nt117){ref-type="table-fn"} = 0.007; interaction p~pathway~ [f](#nt118){ref-type="table-fn"} = 0.091                                                                                                                                                 
  ***OGG1*** **rs159153**                                                                                                                                                                                                                                                                                                                                            
  **Smoking Pack-yrs**          **TT**    **TC**    **CC**                                                                           **T/T**                                                                            **T/C**     **C/C**                                                                                                                          
  Never                         116/139   96/106    18/27                                                                            1^ref^                                                                                                                   1^ref^                                                           1^ref^                                
  \>0--21                        86/91     52/75    15/16                                                                             1.06                                                                             0.73--1.55    0.746                     0.95                     0.67--1.33    0.747                     0.84                     0.42--1.66    0.615
  \>21                           94/96    109/73    24/12                                                                             1.11                                                                             0.76--1.62    0.578                     1.75                     1.26--2.44    0.001                     2.76                     1.43--5.31    0.002
  p ~trend~                                                                                                                                                                                                                          0.610                                                           \<0.001                                                          \<0.001
                                                             interaction p^d = ^0.013; interaction p~gene~ [e](#nt117){ref-type="table-fn"} = 0.040; interaction p~pathway~ [f](#nt118){ref-type="table-fn"} = 0.517                                                                                                                                                 
  ***FEN1*** **rs108499**                                                                                                                                                                                                                                                                                                                                            
  **Smoking Pack-yrs**          **CC**    **CT**    **TT**                                                                           **C/C**                                                                            **C/T**     **T/T**                                                                                                                          
  Never                         95/118    87/108    48/44                                                                            1^ref^                                                                                                                   1^ref^                                                           1^ref^                                
  \>0--21                        64/70     56/86    32/27                                                                             1.02                                                                             0.67--1.54    0.926                     0.96                     0.71--1.29    0.771                     0.90                     0.52--1.56     0.7
  \>21                          124/79     82/78    21/22                                                                             1.99                                                                             1.36--2.91   \<0.001                    1.25                     0.92--1.71    0.156                     0.79                     0.44--1.41    0.424
  p ~trend~                                                                                                                                                                                                                         \<0.001                                                           0.102                                                            0.446
                                                             interaction p^d = ^0.013; interaction p~gene~ [e](#nt117){ref-type="table-fn"} = 0.039; interaction p~pathway~ [f](#nt118){ref-type="table-fn"} = 0.507                                                                                                                                                 

Odds ratios (ORs) are from models with genotype coded as log-additive (treated as continuous) and adjusted for age, sex, clinic, exam date, study phase, and race among all study participants. Excludes 21 individuals who characterized their race/ethnic group as \"other\";

ORs for smoking additionally adjusted for alcohol intake (g/d) and dietary folate intake (mcg/day); ORs for alcohol additionally adjusted for smoking pack-years and dietary folate intake (mcg/d); ORs for dietary folate intake, additionally adjusted for alcohol intake (g/d) and smoking pack-years;

ORs derived from a common baseline model that included the SNP, smoking, alcohol, dietary folate exposure and interaction terms between genotype and smoking, alcohol, dietary folate exposure levels;

Crude interaction p-value;

Within gene region, Bonferroni adjusted interaction p-value, based on the number of SNPs within the respective gene region;

Pathway wide, Bonferroni adjusted interaction p-value, based on 14 investigated BER gene regions.

Genetic Variation in BER Genes, Adenoma Risk and Dietary Folate Intake {#s3d}
----------------------------------------------------------------------

We observed that the association between folate and adenoma risk was modified by two *LIG3* tagSNPs (rs1052536 interaction p~gene = ~0.006, interaction p~pathway = ~0.081; rs3744358 interaction p~gene~ = 0.032, interaction p~pathway = ~0.451) ([Table 5](#pone-0071211-t005){ref-type="table"}). For each of the two *LIG3* tagSNPs, among individuals with one copy of the minor allele, those with the highest level of dietary folate intake had a 31% and 37% decreased adenoma risk compared to those with the lowest level of dietary folate intake for *LIG3* rs1052536 (OR = 0.61; 95%CI = 0.51--0.93; p = 0.015; p ~for\ trend~ = 0.021) and *LIG3* rs3744358 (OR = 0.63; 95%CI = 0.45--0.90; p = 0.010; p ~for\ trend = ~0.003), respectively. Among individuals with two copies of the minor allele, those with the highest level of dietary folate intake had a 72% and 73% decreased adenoma risk compared to those with the lowest level of dietary folate intake for *LIG3* rs1052536 (OR = 0.37; 95%CI = 0.20--0.65; p = 0.0007) and *LIG3* rs3744358 (OR = 0.38; 95%CI = 0.19--0.75; p = 0.006), respectively. Among individuals with 2 copies of the major alleles there was no statistically significant trend across increasing levels of dietary folate intake. When restricting analyses to NHW, similar statistically significant trends were observed for rs1052536 and rs3744358 (data not shown). There is no evidence of LD between *LIG3* tagSNPs rs3744358 and rs*1052536* among NHW.

Genetic Variation in BER Genes, Adenoma Risk and Smoking {#s3e}
--------------------------------------------------------

No statistically significant interactions were observed when we considered smoking status (never/quit/current) or smoking duration, after applying within gene Bonferroni corrections. However, we observed that SNPs in three genes modified the association between smoking pack-years and adenoma risk, with statistically significant interaction tests that survived within gene Bonferroni correction. First, we observed smoking pack-years was modified by *MUTYH* rs10890324 (interaction p~gene = ~0.007, interaction p~pathway = ~0.091) ([Table 5](#pone-0071211-t005){ref-type="table"}). Whereas among individuals with two copies of the major (A) allele there was no association between increasing pack-years and adenoma risk (p ~for\ trend~ = 0.871), among carriers of one copy of the minor (G) allele, having smoked over 21 pack-years was associated with a 76% increased adenoma risk when compared to never smokers (OR = 1.76; 95%CI = 1.29--2.42; p\<0.001; p ~for\ trend~ \<0.001). Among carriers of two minor (G) alleles, smoking more than 21 pack-years was associated with a 3-fold increased risk of adenomas (p ~for\ trend~ \<0.001). Analysis among non-Hispanic Whites was not performed due to sparse data.

Second, the *OGG1* rs159153 SNP modified the association between smoking pack-years and adenoma risk (interaction p~gene = ~0.040, interaction p~pathway = ~0.517). While among individuals with two copies of the major (A) allele there was no association between increasing pack-years and adenoma risk (p ~for\ trend~ = 0.610), among carriers of one copy of the minor (C) allele, having smoked over 21 pack-years was associated with a 75% increased adenoma risk when compared to never smokers (OR = 1.75; 95%CI = 1.26--2.44; p = 0.001; p ~for\ trend~ \<0.001). Among individuals carrying a second minor (C) allele, smoking over 21 pack-years was significantly associated with an almost 3-fold increased risk of adenoma (p ~for\ trend~ \<0.001) when compared to never smokers. Significant trends of increasing adenoma risk among carriers of 1 and 2 minor alleles were observed with increasing smoking years, but there was no statistically significant evidence of interaction between *OGG1* rs159153 and smoking years and adenoma risk.

Finally, the *FEN1* rs108499 SNP also modified the association between smoking pack-years and adenoma risk (interaction p~gene = ~0.039, interaction p~pathway = ~0.507). Among individuals with two copies of the major (C) allele smoking more than 21 pack-years was associated with a 2-fold increased risk of adenomas compared to never smokers (p ~for\ trend~ \<0.001) but there was no association among individuals with either one copy of the minor (T) allele or two copies of the minor (T) allele ([Table 5](#pone-0071211-t005){ref-type="table"}). While a similar significant trend of increasing adenoma risk was observed with increasing smoking years, there was no statistically significant evidence of interaction. Analyses among NHW only were not performed due to sparse data.

Discussion {#s4}
==========

We investigated potential associations between 182 tagSNPs from 14 BER gene regions and their role in modifying the effects of smoking, dietary folate intake and alcohol consumption on colorectal adenoma risk. We observed statistically significant associations between colorectal adenoma risk and polymorphisms in the *FEN1* gene (two tagSNPs) and *NTHL1* gene (one tagSNP) among Asian-Pacific Islanders, and the *APEX1* gene among African-Americans (one tagSNP). Significant associations were also observed for two unlinked tagSNPs in the *NEIL2* gene and rectal adenoma risk. None of the six tagSNPs were found to modify the effects of dietary folate, or alcohol on adenoma risk. However, one of these six tagSNPs, *FEN1* rs108499, was found to modify the effects of smoking on adenoma risk. Moreover, we observed evidence that SNPs in other BER genes modified the effect of smoking *(MUTYH, OGG1)*, alcohol *(LIG3)*, and dietary folate *(LIG3)* on colorectal adenoma risk. Overall, our findings support the hypothesis that oxidative damage induced by these exposures may play an important role in colorectal adenoma development.

Previous studies have investigated BER gene polymorphisms and adenoma risk [@pone.0071211-Stern1], [@pone.0071211-Stern2], [@pone.0071211-Hansen1], [@pone.0071211-Skjelbred1], [@pone.0071211-Gsur1], [@pone.0071211-Berndt1], [@pone.0071211-Gao1]. With one exception [@pone.0071211-Gao1], they have been limited to a handful of candidate SNPs within *XRCC1, PARP1, OGG1,* and *APEX* genes. Even fewer considered the modifier role of alcohol, smoking or dietary folate intake [@pone.0071211-Stern2], [@pone.0071211-Berndt1], [@pone.0071211-Gao1]. Therefore, to our knowledge, this is the first comprehensive examination of the BER pathway and colorectal adenoma risk taking into account relevant environmental risk factors.

We report a two-fold increased adenoma risk associated with SNP rs17111750 located 5′-upstream of APEX1, only among African-Americans. The human *APEX1* protein is an apurinic/apyrimidinic endonuclease that repairs DNA damage caused by oxidative and alkylating agents [@pone.0071211-Simonelli1]. A previous study has reported a positive association between this SNP and colorectal adenoma, and another one reported lack of association with prostate cancer risk [@pone.0071211-Gao1], [@pone.0071211-Barry1]. Among African-Americans *APEX1* rs17111750 is not in LD (r^2^\<0.05) with two other *APEX1* SNPs, rs1048945 and rs1130409, previously reported by us and others to be associated with CRC and adenoma risk [@pone.0071211-Berndt1], [@pone.0071211-Brevik1], [@pone.0071211-Kasahara1], [@pone.0071211-Pardini1].

We observed that the minor alleles of the *FEN1* SNPs rs509360 and rs108499 were associated with a two-fold increased and decreased risk of adenoma, respectively, among Asian-Pacific Islanders. Moreover, among all subjects combined, rs108499 was found to modify the effect of smoking on adenoma risk. Both rs509360 and rs108499 are located 5′-upstream of *FEN1*, occurring within intronic regions of *C11orf9*. A previous study among predominantly NHW found no associations between these *FEN1* SNPs and colorectal adenoma [@pone.0071211-Gao1]. The *FEN1* endonuclease is involved in BER and DNA replication and has been reported to play important roles in genomic stability [@pone.0071211-Chapados1], chronic inflammation, autoimmunity and cancers [@pone.0071211-Zheng1], [@pone.0071211-Kucherlapati1]. In two studies conducted among Chinese populations, polymorphisms in the *FEN1* promoter and 3′-UTR were associated with reduced *FEN1* expression, increased DNA damage and increased risks for lung and CRC [@pone.0071211-Yang1], [@pone.0071211-Liu1].

The *NTHL1* rs2516781 SNP was associated with a two-fold decreased risk of adenoma only among Asian-Pacific Islanders. The NTHL1 protein has DNA N-glycosylase activity as well as apurinic and/or apyrimidinic endonuclease activity [@pone.0071211-Luna1], [@pone.0071211-Aspinwall1], [@pone.0071211-Ikeda1]. The rs2516781 SNP is 3′-downstream of the *NTHL1* gene, an intronic SNP within the solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 (*SLC9A3R2*) gene. *SLC9A3R2* is involved in regulation of SLC9A3, the sodium/hydrogen exchanger involved in intestinal sodium absorption [@pone.0071211-Yun1]. This SNP has not been previously assessed in studies of colorectal adenoma or CRC.

Two *NEIL2* SNPs, rs11785481 and rs3757949, were associated with risk for rectal adenomas. Among NHW these two SNPs are not in LD (r^2^\<0.1). The NEIL2 protein has DNA glycosylase activity and apurinic/apyrimidinic endonuclease activity [@pone.0071211-Simonelli1]. The rs3757949 SNP, is an intronic SNP located within *GATA4,* a gene that codes for a transcription factor relevant for gene expression in gastrointestinal epithelium [@pone.0071211-Temsah1], [@pone.0071211-Molkentin1]. Promoter hyper-methylation and the subsequent transcriptional silencing of *GATA4* are commonly seen in CRC cell lines and primary CRCs [@pone.0071211-Zheng2].

We found evidence that the *MUTYH* rs10890324 SNP, which flanks the 3′-end of *MUTYH*, modified the association between smoking and adenoma risk. The *MUTYH* gene encodes a DNA glycosylase, and germline mutations in highly conserved residues of the *MUTYH* gene predispose individuals to *MUTYH*-associated polyposis coli [@pone.0071211-Cheadle1] as well as sporadic CRC [@pone.0071211-Farrington1], [@pone.0071211-Cleary1]. We also found that the *OGG1* rs159153 SNP, located 5′-upstream of *OGG1*, modified the association between smoking and adenoma risk. The 8-oxoguanine glycosylase 1 (*OGG1)* enzyme can excise the highly mutagenic 8-oxoguanine lesions induced by ROS and normal cellular metabolism [@pone.0071211-Parsons1]. The more commonly investigated *OGG1* Ser326Cys SNP (rs1052133) is not in LD with rs159153 among NHW (r^2^ = 0.08).

Finally, we found evidence that the *LIG3* rs1052536 SNP modified the association between alcohol intake and adenoma risk. In addition, *LIG3* SNPs rs1052536 and rs3744358 modified the association between dietary folate intake and adenoma risk. *LIG3*, a ligase involved in maintaining genomic integrity, encodes proteins present in the mitochondria and nucleus.

Our study had several strengths, including the relatively large sample size and the use of a comprehensive tagSNP approach to thoroughly investigate genetic variation in 14 BER genes. Among the weaknesses of our study is the fact that results are only applicable to the sigmoid colon and rectum, and the fact that cases had colonoscopy performed but not controls; therefore, some controls might have had more proximal polyps out of reach of sigmoidscope [@pone.0071211-Foutch1]. Even though we conducted a large number of tests as part of our analyses, we believe our approach for multiple comparisons adjustment in the SNP main effect analyses and the gene environment analyses is a conservative method of reducing the number of false positive results.

In conclusion, our findings suggest that genetic variation in non-coding BER gene regions can modify the risk of adenoma, particularly in combination with key environmental exposures. These findings highlight a relevant role for oxidative damage induced by these environmental exposures in colorectal adenoma development.
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